- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed B-Cell Non-Hodgkin Lymphoma in Spain
Total 521 results
-
ADC Therapeutics S.A.RecruitingB-Cell Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Spain, Italy, United Kingdom, Belgium, Czechia
-
Gustave Roussy, Cancer Campus, Grand ParisChildren's Oncology GroupUnknownB-cell Non Hodgkin Lymphoma | Mature B-cell Leukemia Burkitt-typeBelgium, France, United Kingdom, Netherlands, Canada, Hungary, Italy, Poland, Spain, China
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
Cellectis S.A.RecruitingB-cell Non-Hodgkin Lymphoma (B-NHL)United States, Spain, France
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B-Cell Non-Hodgkin LymphomaSpain, United States, Czechia, Sweden, Germany, Belgium, Italy, Canada, France, Netherlands, Poland
-
BioInvent International ABRecruitingIndolent B-Cell Non-Hodgkin LymphomaSpain, United States, Brazil, Sweden, Germany, Poland
-
AstraZenecaParexelActive, not recruitingRelapsed or Refractory B-cell Non-Hodgkin LymphomaUnited States, Korea, Republic of, Canada, United Kingdom, Spain, France, Denmark
-
Novartis PharmaceuticalsRecruitingB-cell Non-Hodgkin Lymphoma (B-NHL) | B-cell Acute Lymphoblastic Leukemia (B-ALL)Japan, Italy, Spain, Belgium, Singapore, France, United States, Israel
-
Hoffmann-La RocheActive, not recruitingNon-Hodgkins LymphomaBelgium, Spain, Denmark, Italy, United Kingdom, Israel, United States
-
Hoffmann-La RocheCompletedB-cell Non-Hodgkin LymphomaUnited States, Spain, Korea, Republic of, France, Austria, Poland
-
Bristol-Myers SquibbCompletedCancer - Solid Tumors and B-Cell Non-Hodgkin's LymphomaUnited States, France, Spain, Germany
-
Arvinas Inc.RecruitingRelapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL) | Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)United States, Spain
-
AmgenCompletedB-Cell Non Hodgkin LymphomaUnited States, Spain, United Kingdom, Belgium, Italy, Australia, Canada, Puerto Rico
-
Bristol-Myers SquibbTerminatedAdvanced Solid Tumors | Advanced B-cell NHLUnited States, France, Spain, Germany
-
Regeneron PharmaceuticalsRecruitingB-cell Non-Hodgkins Lymphoma (B-NHL)United States, Spain, United Kingdom, Netherlands
-
PfizerCompletedLymphoma, B-CellUnited States, Spain, France, Switzerland, United Kingdom, Belgium, Germany
-
Hoffmann-La RocheRecruitingNon-Hodgkin's LymphomaBelgium, Australia, Denmark, Spain, Taiwan, France, Italy, United States, Canada, Czechia, New Zealand, Poland, Finland
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced NeutropeniaGermany, Italy, Spain
-
AbbVieRecruitingDiffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | B Cell MalignanciesUnited States, Israel, Australia, France, United Kingdom, Belgium, Spain
-
Hoffmann-La RocheRecruitingMature B-Cell Non-Hodgkin LymphomaUnited States, Spain, Korea, Republic of, France, Denmark, Australia, Germany, Italy
-
Hoffmann-La RocheActive, not recruitingB-cell Non-Hodgkin LymphomaUnited States, Canada, Belgium, Spain, United Kingdom
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Italy, Austria, Canada, France, Germany, Japan, Spain, Sweden, United Kingdom
-
Novartis PharmaceuticalsBristol-Myers SquibbRecruitingNon-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone LymphomaUnited States, Germany, Italy, Korea, Republic of, Spain, Singapore, China, Japan, Australia
-
Regeneron PharmaceuticalsRecruitingB-cell Non-Hodgkin Lymphoma (NHL)United States, Korea, Republic of, China, Spain, Japan, United Kingdom, France, Taiwan, Singapore, Italy, Australia, Canada, Germany, Poland
-
GenmabAbbVieRecruitingFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States, France, Italy, Spain, United Kingdom, Belgium, Denmark, Netherlands, Finland, Czechia, Sweden, Australia, Norway
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
IGM Biosciences, Inc.ADC Therapeutics S.A.Active, not recruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | DLBCLUnited States, Korea, Republic of, Spain, France, Australia, Czechia, Italy
-
Novartis PharmaceuticalsActive, not recruitingChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaFinland, Spain, Korea, Republic of, Israel, Japan, Germany, Singapore
-
Fundacion CRIS de Investigación para Vencer el...BTG International Inc.; BioClever 2005 S.L.; Eurofins ADME, S.L.; NTShub, S.L.TerminatedDiffuse Large B-Cell Lymphoma | Drug ToxicitySpain
-
Hoffmann-La RocheActive, not recruitingNon-Hodgkin Lymphoma | B-Cell LymphomaUnited States, Italy, Canada, Australia, Spain, Denmark, France, Germany, United Kingdom
-
Seagen Inc.TerminatedFollicular B-cell Non-Hodgkin's Lymphoma | Diffuse Large B-cell Lymphoma RefractoryUnited States, Italy, Spain, United Kingdom, Czechia, Poland, France
-
Fundació Institut de Recerca de l'Hospital de la...UnknownLymphoma, Large B-Cell, DiffuseSpain
-
CelgeneCompletedLymphoma, Non-Hodgkin | Precursor Cell Lymphoblastic Leukemia-LymphomaSpain, Netherlands, United States, France, Germany, Italy
-
SanofiMerck Sharp & Dohme LLCActive, not recruitingDiffuse Large B-cell Lymphoma | Classic Hodgkin LymphomaChile, Spain, Argentina
-
Hoffmann-La RocheRecruitingNon-Hodgkin LymphomaUnited States, Israel, Italy, Spain, United Kingdom
-
TG Therapeutics, Inc.TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States, Poland, Australia, Italy, United Kingdom, Israel, Korea, Republic of, Slovakia, Spain
-
CTI BioPharmaCompletedDiffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 LymphomaUnited States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
-
Incyte CorporationActive, not recruitingChronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States, Spain, France, Italy, Belgium, Germany, Austria
-
Nordic NanovectorCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed, Diffuse Large B-cell LymphomaSpain, United Kingdom, Italy, United States, Germany
-
Xencor, Inc.TerminatedDiffuse Large-cell B-cell LymphomaSpain, United States, France
-
Regeneron PharmaceuticalsRecruitingB-Cell Non-Hodgkin Lymphoma (B-NHL)Taiwan, Spain, Korea, Republic of, Thailand, Italy, Malaysia, Turkey, Australia
-
Hospital Universitario Principe de AsturiasUnknownDiffuse Large B-Cell Lymphoma (DLBCL)Spain
-
Molecular Templates, Inc.TerminatedLeukemia, Lymphocytic, Chronic, B-Cell | Diffuse Large B Cell Lymphoma | Blood Cancer | Hematological Malignancy | Small Lymphocytic Leukemia | Non-Hodgkin's B-cell LymphomaUnited States, Canada, Georgia, Belarus, Spain, Israel, Moldova, Republic of, Poland, Serbia, Ukraine
-
Bristol-Myers SquibbCompletedLymphoma. Non-HodgkinGermany, Italy, United States, Spain, Netherlands, Australia, United Kingdom, Belgium, France, Canada, Sweden, Singapore
-
Grupo Español de Linfomas y Transplante Autólogo...Celgene Corporation; Dynamic Science S.L.; Thermo Fisher Scientific, IncCompleted
-
Hoffmann-La RocheCompletedRelapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell LymphomaUnited States, Spain, United Kingdom
-
EnteromeRecruitingFollicular Lymphoma | Marginal Zone LymphomaUnited States, Italy, Spain
-
MEI Pharma, Inc.Kyowa Kirin, Inc.TerminatedPhase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Taiwan, Australia, Poland, Italy, Canada, Georgia, Greece, Hungary, Netherlands, New Zealand, Serbia, Turkey
-
Gilead SciencesWithdrawnDiffuse Large B-Cell Lymphoma | Mediastinal B-cell LymphomaItaly, Spain, France, Poland
-
Instituto de Investigación Biomédica de SalamancaCarlos III Health InstituteRecruiting